Source: Milan 2017 - Educational material
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence. Milan 2017 - Educational material

Member's Comments

No comment yet.

Related content which might interest you: Multidrug-resistant tuberculosis in a tuberculosis unit – results of five years Source: Eur Respir J 2006; 28: Suppl. 50, 377s Year: 2006 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Multidrug-resistant tuberculosis Source: Annual Congress 2008 - The thoracic surgeon facing infection Year: 2008 Multi-drug-resistant tuberculosis Source: ERS Course 2018 - Summer school of paediatric respiratory medicine Year: 2018 Multi-drug-resistant tuberculosis Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019 Comorbidome in multidrug-resistant tuberculosis patients Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Multidrug-resistant tuberculosis (MDR-TB) Source: Breathe 2010; 6: 283 Year: 2010 Management and treatment of multidrug-resistant tuberculosis Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis Source: Eur Respir J 2013; 41: 1393-1400 Year: 2013 Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001 Immunological response in HIV-associated tuberculosis and the implications of HIV in the search for a tuberculosis vaccine Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news? Year: 2007 Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008 Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 Multidrug-resistant tuberculosis in children: evidence from global surveillance Source: Eur Respir J 2013; 42: 701-707 Year: 2013 Epidemiology of TB Source: Eur Respir Mon 2012; 58: 14-25 Year: 2012 Isolation of mycobacterium tuberculosis and mycobacterium africanum from HIV/AIDS patients with pulmonary tuberculosis in Ibadan, Nigeria Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007